Skip to main content

Advertisement

Springer Nature Link
Log in

Nutrition

Y a-t-il une place pour la supplémentation en acides gras oméga-3, en acides linoléiques conjugués et en micronutriments pendant et après les traitements d’un cancer du sein ?

  • Recommandations/Guidelines
  • Published:
Oncologie

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+
from $39.99 /Month
  • Starting from 10 chapters or articles per month
  • Access and download chapters and articles from more than 300k books and 2,500 journals
  • Cancel anytime
View plans

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Références

  1. Abdi-Dezfuli F, Frøyland L, Thorsen T, et al. (1997) Eicosapentaenoic acid and sulphur substituted fatty acid analogues inhibit the proliferation of human breast cancer cells in culture. Breast Cancer Res Treat 45: 229–239

    Article  PubMed  CAS  Google Scholar 

  2. Altenburg JD, Siddiqui RA (2009) Omega-3 polyunsaturated fatty acids down-modulate cxcr4 expression and function in MDA-MB-231 breast cancer cells. Mol Cancer Res 7: 1013–1020

    Article  PubMed  CAS  Google Scholar 

  3. Amarù DL, Field CJ (2009) Conjugated linoleic acid decreases MCF-7 human breast cancer cell growth and insulin-like growth factor-1 receptor levels. Lipids 44: 449–458

    Article  PubMed  Google Scholar 

  4. Amir E, Simmons CE, Freedman OC, et al. (2010) A phase II trial exploring the effects of high-dose (10,000 IU/day) vitamin D(3) in breast cancer patients with bone metastases. Cancer 116: 284–291

    Article  PubMed  CAS  Google Scholar 

  5. Argyriou AA, Chroni E, Koutras A, et al. (2005) Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial. Neurology 64: 26–31

    Article  PubMed  CAS  Google Scholar 

  6. Argyriou AA, Chroni E, Koutras A, et al. (2006) A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results. Support Care Cancer 14: 1134–1140

    Article  PubMed  Google Scholar 

  7. Babu JR, Sundravel S, Arumugam G, et al. (2000) Salubrious effect of vitamin C and vitamin E on tamoxifen-treated women in breast cancer with reference to plasma lipid and lipoprotein levels. Cancer Lett 151: 1–5

    Article  PubMed  CAS  Google Scholar 

  8. Bagga D, Capone S, Wang HJ, et al. (1997) Dietary modulation of omega-3/omega-6 polyunsaturated fatty acid ratios in patients with breast cancer. J Natl Cancer Inst 89: 1123–1131

    Article  PubMed  CAS  Google Scholar 

  9. Barton DL, Loprinzi CL, Quella SK, et al. (1998) Prospective evaluation of vitamin e for hot flashes in breast cancer survivors. J Clin Oncol 16: 495–500

    PubMed  CAS  Google Scholar 

  10. Belguise K, Guo S, Sonenshein GE (2007) Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells. Cancer Res 67: 5763–5770

    Article  PubMed  CAS  Google Scholar 

  11. Bernard-Gallon DJ, Vissac-Sabatier C, Antoine-Vincent D, et al. (2002) Differential effects of n-3 and n-6 polyunsaturated fatty acids on BRCA1 and BRCA2 gene expression in breast cell lines. Br J gene expression in breast cell lines. Br J Nutr 87: 281–289

    Article  PubMed  CAS  Google Scholar 

  12. Bigelow RLH, Cardelli JA (2006) The green tea catechins, (−)-epigallocatechin-3-gallate (EGCG) and (−)-epicatechin-3-gallate (ECG), inhibit HGF/MET signaling in immortalized and tumorigenic breast epithelial cells. Oncogene 25: 1922–1930

    Article  PubMed  CAS  Google Scholar 

  13. Biglia N, Sgandurra P, Peano E, et al. (2009) Non-hormonal treatment of hot flushes in breast cancer survivors: gabapentin vs vitamin E. Climacteric 12: 310–318

    Article  PubMed  CAS  Google Scholar 

  14. Bougnoux P, Germain E, Chajès V, et al. (1999) Cytotoxic drugs efficacy correlates with adipose tissue docosahexaenoic acid level in locally advanced breast carcinoma. Br J Cancer 79: 1765–1769

    Article  PubMed  CAS  Google Scholar 

  15. Bougnoux P, Hajjaji N, Ferrasson MN, et al. (2009) Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial. Br J Cancer 101: 1978–1985

    Article  PubMed  CAS  Google Scholar 

  16. Bougnoux P, Koscielny S, Chajès V, et al. (1994) Alpha-linolenic acid content of adipose breast tissue: a host determinant of the risk of early metastasis in breast cancer. Br J Cancer 70: 330–334

    Article  PubMed  CAS  Google Scholar 

  17. Breedlove HA, Smith AM, Burk RF, et al. (2006) Serum selenium measurements in women with early-stage breast cancer with and without chemotherapy-induced ovarian failure. Breast Cancer Res Treat 97: 225–230

    Article  PubMed  CAS  Google Scholar 

  18. Bruemmer B, Patterson RE, Cheney C, et al. (2003) The association between vitamin C and vitamin E supplement use before hematopoietic stem cell transplant and outcomes to two years. J Am Diet Assoc 103: 982–990

    Article  PubMed  Google Scholar 

  19. Chajes V, Lavillonniere F, Maillard V, et al. (2003) Conjugated linoleic acid content in breast adipose tissue of breast cancer patients and the risk of metastasis. Nutr Cancer 45: 17–23

    Article  PubMed  CAS  Google Scholar 

  20. Colas S, Mahéo K, Denis F, et al. (2006) Sensitization by dietary docosahexaenoic acid of rat mammary carcinoma to anthracycline: a role for tumor vascularization. Clin Cancer Res 12: 5879–5886

    Article  PubMed  CAS  Google Scholar 

  21. Colas S, Paon L, Denis F, et al. (2004) Enhanced radiosensitivity of rat autochtonous mammary tumors by dietary docosahexaenoic acid. Int J Cancer 109: 449–454

    Article  PubMed  CAS  Google Scholar 

  22. Creagan ET, Moertel CG, O’Fallon JR, et al. (1979) Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med 301: 687–690

    Article  PubMed  CAS  Google Scholar 

  23. Crew KD, Shane E, Cremers S, et al. (2009) High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy. J Clin Oncol 27: 2151–2156

    Article  PubMed  CAS  Google Scholar 

  24. de Souza Fêde AB, Bensi CG, Trufelli DC, et al. (2007) Multivitamins do not improve radiation therapy-related fatigue: results of a double blind randomized crossover trial. Am J Clin Oncol 30: 432–436

    Article  PubMed  Google Scholar 

  25. DeGraffenried LA, Friedrichs WE, Fulcher L, et al. (2003) Eicosapentaenoic acid restores tamoxifen sensitivity in breast cancer cells with high akt activity. Ann Oncol 14: 1051–1056

    Article  PubMed  CAS  Google Scholar 

  26. Delanian S, Porcher R, Balla-Mekias S, et al. (2003) Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis. J Clin Oncol 21: 2545–2550

    Article  PubMed  CAS  Google Scholar 

  27. Delanian S, Porcher R, Rudant J, et al. (2005) Kinetics of response to long-term treatment combining pentoxifylline and tocopherol in patients with superficial radiation-induced fibrosis. J Clin Oncol 23: 8570–8579

    Article  PubMed  Google Scholar 

  28. Dou QP, Landis-Piwowar KR, Chen D, et al. (2008) Green tea polyphenols as a natural tumour cell proteasome inhibitor. Inflammopharmacology 16: 208–212

    Article  PubMed  CAS  Google Scholar 

  29. Druesne-Pecollo N, Latino-Martel P, Norat T, et al. (2010) Beta-carotene supplementation and cancer risk: a systematic review and metaanalysis of randomized controlled trials. Int J Cancer 127: 172–184

    Article  PubMed  CAS  Google Scholar 

  30. Fink BN, Gaudet MM, Britton JA, et al. (2006) Fruits, vegetables, and micronutrient intake in relation to breast cancer survival. Breast Cancer Res Treat 98: 199–208

    Article  PubMed  CAS  Google Scholar 

  31. Fite A, Goua M, Wahle KWJ, et al. (2007) Potentiation of the antitumour effect of docetaxel by conjugated linoleic acids (CLAs) in breast cancer cells in vitro. Prostaglandins Leukot Essent Fatty Acids 77: 87–96

    Article  PubMed  CAS  Google Scholar 

  32. Fleischauer AT, Simonsen N, Arab L (2003) Antioxidant supplements and risk of breast cancer recurrence and breast cancer-related mortality among postmenopausal women. Nutr Cancer 46: 15–22

    Article  PubMed  CAS  Google Scholar 

  33. Flowers M, Thompson PA (2009) T10c12 conjugated linoleic acid suppresses HER2 protein and enhances apoptosis in SKBR3 breast cancer cells: possible role of COX2. PLoS One 4: e5342

    Article  PubMed  Google Scholar 

  34. Formelli F, Meneghini E, Cavadini E, et al. (2009) Plasma retinol and prognosis of postmenopausal breast cancer patients. Cancer Epidemiol Biomarkers Prev 18: 42–48

    Article  PubMed  CAS  Google Scholar 

  35. Gewirtz DA, Hilliker ML, Wilson EN (2009) Promotion of autophagy as a mechanism for radiation sensitization of breast tumor cells. Radiother Oncol 92: 323–328

    Article  PubMed  CAS  Google Scholar 

  36. Gold EB, Flatt SW, Pierce JP, et al. (2006) Dietary factors and vasomotor symptoms in breast cancer survivors: the WHEL study. Menopause 13: 423–433

    Article  PubMed  Google Scholar 

  37. Goodwin PJ, Ennis M, Pritchard KI, et al. (2009) Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol 27: 3757–3763

    Article  PubMed  CAS  Google Scholar 

  38. Gothard L, Cornes P, Earl J, et al. (2004) Double blind placebocontrolled randomized trial of vitamin E and pentoxifylline in patients with chronic arm lymphoedema and fibrosis after surgery and radiotherapy for breast cancer. Radiother Oncol 73: 133–139

    Article  PubMed  CAS  Google Scholar 

  39. Guo S, Yang S, Taylor C, et al. (2005) Green tea polyphenol epigallocatechin-3 gallate (EGCG) affects gene expression of breast cancer cells transformed by the carcinogen 7,12-dimethylbenz[a]anthracene. J Nutr 135: 2978S–2986S

    PubMed  CAS  Google Scholar 

  40. Haddad P, Kalaghchi B, Amouzegar-Hashemi F (2005) Pentoxifylline and vitamin E combination for superficial radiation-induced fibrosis: a phase II clinical trial. Radiother Oncol 77: 324–326

    Article  PubMed  CAS  Google Scholar 

  41. Hines SL, Jorn HKS, Thompson KM, et al. (2010) Breast cancer survivors and vitamin D: a review. Nutrition 26: 255–262

    Article  PubMed  CAS  Google Scholar 

  42. Israël L, Hajji O, Grefft-Alami A, et al. (1985) Augmentation par la vitamine A des effets de la chimiothérapie dans les cancers du sein métastasés après la ménopause. Essai randomisé sur 100 malades. Ann Med Interne (Paris) 136: 551–554

    Google Scholar 

  43. Khan QJ, Reddy PS, Kimler BF, et al. (2010) Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer. Breast Cancer Res Treat 119: 111–118

    Article  PubMed  CAS  Google Scholar 

  44. Kottschade LA, Sloan JA, Mazurczak MA, et al. (2010) The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial. Support Care Cancer [Epub ahead of print]

  45. Landis-Piwowar KR, Huo C, Chen D, et al. (2007) A novel prodrug of the green tea polyphenol (−)-epigallocatechin-3-gallate as a potential anticancer agent. Cancer Res 67: 4303–4310

    Article  PubMed  CAS  Google Scholar 

  46. Lawenda BD, Smith DE, Xu L, et al. (2007) Do the dietary supplements epigallocatechin gallate or vitamin e cause a radiomodifying response on tumors in vivo? A pilot study with murine breast carcinoma. J Soc Integr Oncol 5: 11–17

    Article  PubMed  CAS  Google Scholar 

  47. Lesperance ML, Olivotto IA, Forde N, et al. (2002) Mega-dose vitamins and minerals in the treatment of non-metastatic breast cancer: an historical cohort study. Breast Cancer Res Treat 76: 137–143

    Article  PubMed  CAS  Google Scholar 

  48. Lindsey AM, Gross G, Twiss J, et al. (2002) Postmenopausal survivors of breast cancer at risk for osteoporosis: nutritional intake and body size. Cancer Nurs 25: 50–56

    Article  PubMed  Google Scholar 

  49. Lockwood K, Moesgaard S, Folkers K (1994) Partial and complete regression of breast cancer in patients in relation to dosage of coenzyme Q10. Biochem Biophys Res Commun 199: 1504–1508

    Article  PubMed  CAS  Google Scholar 

  50. Lockwood K, Moesgaard S, Hanioka T, et al. (1994) Apparent partial remission of breast cancer in “high risk” patients supplemented with nutritional antioxidants, essential fatty acids and coenzyme Q10. Mol Aspects Med 15(Suppl): s231–s240

    Article  PubMed  Google Scholar 

  51. Magnusson M, Hoglund P, Johansson K, et al. (2009) Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: a phase II, double blind, placebo-controlled randomized clinical trial (PTX-5). Eur J Cancer 45: 2488–2495

    Article  PubMed  CAS  Google Scholar 

  52. Mahéo K, Vibet S, Steghens JP, et al. (2005) Differential sensitization of cancer cells to doxorubicin by DHA: a role for lipoperoxidation. Free Radic Biol Med 39: 742–751

    Article  PubMed  Google Scholar 

  53. Martel P, Bachmann P, Chauvin F, et al. (2009) Recommandations pour la pratique clinique: Nice-Saint-Paul-de-Vence 2009 « cancers du sein » et « soins de support »: nutrition. Oncologie 11: 711–728

    Google Scholar 

  54. Menéndez JA, del Mar Barbacid M, Montero S, et al. (2001) Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells. Eur J Cancer 37: 402–413

    Article  PubMed  Google Scholar 

  55. Menendez JA, Ropero S, Lupu R, et al. (2004) Omega-6 polyunsaturated fatty acid gamma-linolenic acid (18:3 n-6) enhances docetaxel (taxotere) cytotoxicity in human breast carcinoma cells: relationship to lipid peroxidation and her-2/neu expression. Oncol Rep 11: 1241–1252

    PubMed  CAS  Google Scholar 

  56. Nechuta S, Lu W, Chen Z, et al. (2011) Vitamin supplement use during breast cancer treatment and survival: a prospective cohort study. Cancer Epidemiol Biomarkers Prev 20: 262–271

    Article  PubMed  CAS  Google Scholar 

  57. Ogunleye AA, Xue F, Michels KB (2010) Green tea consumption and breast cancer risk or recurrence: a meta-analysis. Breast Cancer Res Treat 119: 477–484

    Article  PubMed  Google Scholar 

  58. Pace A, Giannarelli D, Galiè E, et al. (2010) Vitamin E neuroprotection for cisplatin neuropathy: a randomized, placebo-controlled trial. Neurology 74: 762–766

    Article  PubMed  CAS  Google Scholar 

  59. Pace A, Savarese A, Picardo M, et al. (2003) Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy. J Clin Oncol 21: 927–931

    Article  PubMed  CAS  Google Scholar 

  60. Portakal O, Ozkaya O, Erden Inal M, et al. (2000) Coenzyme Q10 concentrations and antioxidant status in tissues of breast cancer patients. Clin Biochem 33: 279–284

    Article  PubMed  CAS  Google Scholar 

  61. Poulter JM, White WF, Dickerson JW (1984) Ascorbic acid supplementation and five year survival rates in women with early breast cancer. Acta Vitaminol Enzymol 6: 175–182

    PubMed  CAS  Google Scholar 

  62. Premkumar VG, Yuvaraj S, Vijayasarathy K, et al. (2007) Effect of coenzyme Q10, riboflavin and niacin on serum CEA and CA 15–3 levels in breast cancer patients undergoing tamoxifen therapy. Biol Pharm Bull 30: 367–370

    Article  PubMed  CAS  Google Scholar 

  63. Premkumar VG, Yuvaraj S, Vijayasarathy K, et al. (2007) Serum cytokine levels of interleukin-1beta, -6, -8, tumour necrosis factor-alpha and vascular endothelial growth factor in breast cancer patients treated with tamoxifen and supplemented with coenzyme Q10, riboflavin and niacin. Basic Clin Pharmacol Toxicol 100: 387–391

    Article  PubMed  CAS  Google Scholar 

  64. Recchia F, Sica G, Candeloro G, et al. (2009) Beta-interferon, retinoids and tamoxifen in metastatic breast cancer: long-term follow-up of a phase II study. Oncol Rep 21: 1011–1016

    Article  PubMed  CAS  Google Scholar 

  65. Rock CL, Demark-Wahnefried W (2002) Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J Clin Oncol 20: 3302–3316

    Article  PubMed  Google Scholar 

  66. Rock CL, Flatt SW, Natarajan L, et al. (2005) Plasma carotenoids and recurrence-free survival in women with a history of breast cancer. J Clin Oncol 23: 6631–6638

    Article  PubMed  CAS  Google Scholar 

  67. Rose DP, Connolly JM, Rayburn J, et al. (1995) Influence of diets containing eicosapentaenoic or docosahexaenoic acid on growth and metastasis of breast cancer cells in nude mice. J Natl Cancer Inst 87: 587–592

    Article  PubMed  CAS  Google Scholar 

  68. Rosengren RJ (2003) Catechins and the treatment of breast cancer: possible utility and mechanistic targets. IDrugs 6: 1073–1078

    PubMed  CAS  Google Scholar 

  69. Sartippour MR, Pietras R, Marquez-Garban DC, et al. (2006) The combination of green tea and tamoxifen is effective against breast cancer. Carcinogenesis 27: 2424–2433

    Article  PubMed  CAS  Google Scholar 

  70. Sartippour MR, Shao ZM, Heber D, et al. (2002) Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells. J Nutr 132: 2307–2311

    PubMed  CAS  Google Scholar 

  71. Seely D, Mills EJ, Wu P, et al. (2005) The effects of green tea consumption on incidence of breast cancer and recurrence of breast cancer: a systematic review and meta-analysis. Integr Cancer Ther 4: 144–155

    Article  PubMed  Google Scholar 

  72. Simmons C, Amir E, Dranitsaris G, et al. (2009) Altered calcium metabolism in patients on long-term bisphosphonate therapy for metastatic breast cancer. Anticancer Res 29: 2707–2711

    PubMed  CAS  Google Scholar 

  73. Tang Y, Zhao DY, Elliott S, et al. (2007) Epigallocatechin-3-gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression. Int J Oncol 31: 705–711

    PubMed  CAS  Google Scholar 

  74. Thangapazham RL, Passi N, Maheshwari RK (2007) Green tea polyphenol and epigallocatechin gallate induce apoptosis and inhibit invasion in human breast cancer cells. Cancer Biol Ther 6: 1938–1943

    Article  PubMed  CAS  Google Scholar 

  75. Veronesi U, Mariani L, Decensi A, et al. (2006) Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer. Ann Oncol 17: 1065–1071

    Article  PubMed  CAS  Google Scholar 

  76. Waltman NL, Ott CD, Twiss JJ, et al. (2009) Vitamin D insufficiency and musculoskeletal symptoms in breast cancer survivors on aromatase inhibitor therapy. Cancer Nurs 32: 143–150

    Article  PubMed  Google Scholar 

  77. Yee LD, Lester JL, Cole RM, et al. (2010) Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition. Am J Clin Nutr 91: 1185–1194

    Article  PubMed  CAS  Google Scholar 

  78. Yuvaraj S, Premkumar VG, Shanthi P, et al. (2009) Effect of coenzyme Q10, riboflavin and niacin on tamoxifen treated postmenopausal breast cancer women with special reference to blood chemistry profiles. Breast Cancer Res Treat 114: 377–384

    Article  PubMed  CAS  Google Scholar 

  79. Yuvaraj S, Premkumar VG, Vijayasarathy K, et al. (2008) Augmented antioxidant status in tamoxifen treated postmenopausal women with breast cancer on co-administration with coenzyme Q10, niacin and riboflavin. Cancer Chemother Pharmacol 61: 933–941

    Article  PubMed  CAS  Google Scholar 

Références électroniques

  1. Anses (2010) Avis de l’Agence franç aise de sé curité sanitaire des aliments relatif à l’actualisation des apports nutritionnels conseillé s pour les acides gras. http://www.afssa.fr/Documents/NUT2006sa0359.pdf. Accessed 29/08 2011

  2. INCa (2009) Nutrition et prévention des cancers: des connaissances scientifiques aux recommandations. Boulogne-Billancourt (http://www.e-cancer.fr)

Download references

Authors
  1. S. Schneider
    View author publications

    Search author on:PubMed Google Scholar

  2. P. Bachmann
    View author publications

    Search author on:PubMed Google Scholar

  3. P. Latino-Martel
    View author publications

    Search author on:PubMed Google Scholar

  4. M. Simon
    View author publications

    Search author on:PubMed Google Scholar

  5. M. -P. Vasson
    View author publications

    Search author on:PubMed Google Scholar

  6. L. Zelek
    View author publications

    Search author on:PubMed Google Scholar

About this article

Cite this article

Schneider, S., Bachmann, P., Latino-Martel, P. et al. Nutrition. Oncologie 13, 806–816 (2011). https://doi.org/10.1007/s10269-011-2092-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10269-011-2092-y